Oxurion NV (EBR:OXUR)
Belgium · Delayed Price · Currency is EUR 0.0070
0.00 (0.00%)
Feb 10, 2026, 9:46 AM CET
Oxurion NV Market Cap
Oxurion NV has a market cap or net worth of €490.69 thousand as of February 10, 2026. Its market cap has decreased by -43.81% in one year.
Market Cap
490.69K
Enterprise Value
11.31M
Revenue
2.00K
Ranking
n/a
PE Ratio
0.02
Stock Price
€0.01
Market Cap Chart
Since July 7, 2006, Oxurion NV's market cap has decreased from 100.46M to 490.69K, a decrease of -99.51%. That is a compound annual growth rate of -23.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 490.69K | 8.87% |
| Dec 31, 2025 | 450.71K | -41.17% |
| Dec 31, 2024 | 766.13K | -73.79% |
| Dec 29, 2023 | 2.92M | -62.57% |
| Dec 30, 2022 | 7.81M | -88.99% |
| Dec 31, 2021 | 70.93M | -27.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 49.78B |
| argenx SE | 42.57B |
| Financière de Tubize | 10.02B |
| Hyloris Pharmaceuticals | 207.20M |
| Onward Medical | 183.88M |
| European Medical Solutions | 22.51M |
| Celyad Oncology | 8.06M |
| BioSenic | 1.50M |